Who
Mark Voll
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, RenovoRx; Chief Financial Officer, Techpoint; Chief Financial Officer, Aquantia; Chief Financial Officer, Techwell.
In numbers
- Trades disclosed
- 58
- Buys
- 2
- Sells
- 4
- Bought
- $39K
- Sold
- $769K
- Companies
- 4
- Companies where not an officer
- 0
- First trade
- 22 Dec 2006
- Last trade
- 10 Sep 2026
- Last filed
- 15 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Sep 2026filed 15 Sep 2026 | RNXT RenovoRxBiotechnology | SEC FORM 4 Code A | —80,000 at $0.00 | filing |
| 10 Sep 2026filed 15 Sep 2026 | RNXT RenovoRxBiotechnology | SEC FORM 4 Code A | —80,000 at $0.00 | filing |
| 19 May 2026filed 21 May 2026 | RNXT RenovoRxBiotechnology | SEC FORM 4 Bought | $20K25,000 at $0.7876 | filing |
| 19 May 2026filed 21 May 2026 | RNXT RenovoRxBiotechnology | SEC FORM 4 Bought | $20K25,000 at $0.79 | filing |
| 3 Apr 2026filed 7 Apr 2026 | RNXT RenovoRxBiotechnology | SEC FORM 4 Code A | —80,000 at $0.00 | filing |
| 3 Apr 2026filed 7 Apr 2026 | RNXT RenovoRxBiotechnology | SEC FORM 4 Code A | —80,000 at $0.00 | filing |
| 25 Mar 2026filed 27 Mar 2026 | RNXT RenovoRxBiotechnology | SEC FORM 4 Code A | —12,380 at $0.00 | filing |
| 25 Mar 2026filed 27 Mar 2026 | RNXT RenovoRxBiotechnology | SEC FORM 4 Code A | —12,380 at $0.00 | filing |
| 20 Mar 2026filed 24 Mar 2026 | RNXT RenovoRxBiotechnology | SEC FORM 4 Bought | —97,200 | filing |
| 20 Mar 2026filed 24 Mar 2026 | RNXT RenovoRxoption or derivative · Biotechnology | SEC FORM 4 Code P | —48,600 | filing |
| 20 Mar 2026filed 24 Mar 2026 | RNXT RenovoRxoption or derivative · Biotechnology | SEC FORM 4 Code P | —48,600 | filing |
| 20 Mar 2026filed 24 Mar 2026 | RNXT RenovoRxBiotechnology | SEC FORM 4 Bought | —97,200 | filing |
| 8 Nov 2019filed 12 Nov 2019 | Techpointoption or derivative | SEC FORM 4 Code A | —80,000 at $0.00 | filing |
| 1 Apr 2019filed 2 Apr 2019 | Aquantia | SEC FORM 4 Code F | $34K3,802 at $9.06 | filing |
| 22 Feb 2019filed 26 Feb 2019 | Aquantia | SEC FORM 4 Code A | —73,171 at $0.00 | filing |
| 5 Nov 2018filed 6 Nov 2018 | Aquantiaoption or derivative | SEC FORM 4 Code M | $10K1,467 at $7.10 | filing |
| 5 Nov 2018filed 6 Nov 2018 | Aquantia | SEC FORM 4 Code M | $10K1,467 at $7.10 | filing |
| 7 Jun 2018filed 8 Jun 2018 | Aquantia | SEC FORM 4 Code M | $35K4,988 at $7.10 | filing |
| 7 Jun 2018filed 8 Jun 2018 | Aquantiaoption or derivative | SEC FORM 4 Code M | $35K4,988 at $7.10 | filing |
| 25 Apr 2018filed 27 Apr 2018 | Aquantiaoption or derivative | SEC FORM 4 Code A | —44,500 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.